Related references
Note: Only part of the references are listed.Lipid raft connection between extrinsic and intrinsic apoptotic pathways
Consuelo Gajate et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2009)
Involvement of mitochondria and recruitment of Fas/CD95 signaling in lipid rafts in resveratrol-mediated antimyeloma and antileukemia actions
M. Reis-Sobreiro et al.
ONCOGENE (2009)
Involvement of Raft Aggregates Enriched in Fas/CD95 Death-Inducing Signaling Complex in the Antileukemic Action of Edelfosine in Jurkat Cells
Consuelo Gajate et al.
PLOS ONE (2009)
Perifosine synergistically enhances TRAIL-induced myeloma cell apoptosis via up-regulation of death receptors
Ebenezer David et al.
CLINICAL CANCER RESEARCH (2008)
The promise of cancer therapeutics targeting the TNF-related apoptosis-inducing ligand and TRAIL receptor pathway
S. Wang
ONCOGENE (2008)
Proapoptotic role of Hsp90 by its interaction with c-Jun N-terminal kinase in lipid rafts in edelfosine-mediated antileukemic therapy
T. Nieto-Miguel et al.
ONCOGENE (2008)
Fas receptor clustering and involvement of the death receptor pathway in rituximab-mediated apoptosis with concomitant sensitization of lymphoma B cells to Fas-induced apoptosis
Alia J. Stel et al.
JOURNAL OF IMMUNOLOGY (2007)
Edelfosine and perifosine induce selective apoptosis in multiple myeloma by recruitment of death receptors and downstream signaling molecules into lipid rafts
Consuelo Gajate et al.
BLOOD (2007)
Elevated levels of cholesterol-rich lipid rafts in cancer cells are correlated with apoptosis sensitivity induced by cholesterol-depleting agents
YC Li et al.
AMERICAN JOURNAL OF PATHOLOGY (2006)
Fas/CD95 death receptor and lipid rafts: New targets for apoptosis-directed cancer therapy
Faustino Mollinedo et al.
DRUG RESISTANCE UPDATES (2006)
Cytoskeleton-mediated death receptor and ligand concentration in lipid rafts forms apoptosis-promoting clusters in cancer chemotherapy
C Gajate et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2005)
Cholesteryl esters in malignancy
MR Tosi et al.
CLINICA CHIMICA ACTA (2005)
Intracellular triggering of fas aggregation and recruitment of apoptotic molecules into fas-enriched rafts in selective tumor cell apoptosis
C Gajate et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2004)
Redistribution of CD95, DR4 and DR5 in rafts accounts for the synergistic toxicity of resveratrol and death receptor ligands in colon carcinoma cells
D Delmas et al.
ONCOGENE (2004)
Cholesterol and prostate cancer
MR Freeman et al.
JOURNAL OF CELLULAR BIOCHEMISTRY (2004)
Cisplatin-induced CD95 redistribution into membrane lipid rafts of HT29 human colon cancer cells
S Lacour et al.
CANCER RESEARCH (2004)
Resveratrol-induced apoptosis is associated with Fas redistribution in the rafts and the formation of a death-inducing signaling complex in colon cancer cells
D Delmas et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2003)
The CD95(APO-1/Fas) DISC and beyond
ME Peter et al.
CELL DEATH AND DIFFERENTIATION (2003)
Biological activities, mechanisms of action and biomedical prospect of the antitumor ether phospholipid ET-18-OCH3 (edelfosine), a proapoptotic agent in tumor cells
C Gajate et al.
CURRENT DRUG METABOLISM (2002)
The antitumor ether lipid ET-18-OCH3 induces apoptosis through translocation and capping of Fas/CD95 into membrane rafts in human leukemic cells
C Gajate et al.
BLOOD (2001)
Share Paper
